| Optimization of humanized IgGs in glycoengineered Pichia pastoris H Li, N Sethuraman, TA Stadheim, D Zha, B Prinz, N Ballew, P Bobrowicz, ... Nature biotechnology 24 (2), 210-215, 2006 | 661 | 2006 |
| Production of monoclonal antibodies by glycoengineered Pichia pastoris TI Potgieter, M Cukan, JE Drummond, NR Houston-Cummings, Y Jiang, ... Journal of biotechnology 139 (4), 318-325, 2009 | 209 | 2009 |
| IgG2m4, an engineered antibody isotype with reduced Fc function Z An, G Forrest, R Moore, M Cukan, P Haytko, L Huang, S Vitelli, JZ Zhao, ... MAbs 1 (6), 572-579, 2009 | 140 | 2009 |
| Glycoengineered Pichia produced anti-HER2 is comparable to trastuzumab in preclinical study N Zhang, L Liu, C Dan Dumitru, NRH Cummings, M Cukan, Y Jiang, Y Li, ... MAbs 3 (3), 289-298, 2011 | 115 | 2011 |
| Recombinant human lactoferrin expressed in glycoengineered Pichia pastoris: effect of terminal N-acetylneuraminic acid on in vitro secondary humoral immune … BK Choi, JK Actor, S Rios, M d’Anjou, TA Stadheim, S Warburton, ... Glycoconjugate journal 25, 581-593, 2008 | 82 | 2008 |
| Purification process development of a recombinant monoclonal antibody expressed in glycoengineered Pichia pastoris Y Jiang, F Li, D Zha, TI Potgieter, T Mitchell, R Moore, M Cukan, ... Protein Expression and Purification 76 (1), 7-14, 2011 | 41 | 2011 |
| Characterization of N-Linked Glycosylation on Recombinant Glycoproteins Produced in Pichia pastoris Using ESI-MS and MALDI-TOF B Gong, M Cukan, R Fisher, H Li, TA Stadheim, T Gerngross Glycomics: Methods and Protocols, 213-223, 2009 | 22 | 2009 |
| Binding of DC-SIGN to glycoproteins expressed in glycoengineered Pichia pastoris MC Cukan, D Hopkins, I Burnina, M Button, E Giaccone, ... Journal of immunological methods 386 (1-2), 34-42, 2012 | 19 | 2012 |
| A high-throughput purification of monoclonal antibodies from glycoengineered Pichia pastoris Y Jiang, F Li, M Button, M Cukan, R Moore, N Sharkey, H Li Protein expression and purification 74 (1), 9-15, 2010 | 18 | 2010 |
| Glycoengineered Pichia produced anti-HER2 is comparable to trastuzumab in preclinical study. mAbs 2011; 3: 289-98; PMID: 21487242 N Zhang, L Liu, CD Dumitru, NR Cummings, M Cukan, Y Jiang, Y Li, F Li, ... | 3 | |
| Erratum to “Binding of DC-SIGN to glycoproteins expressed in glycoengineered Pichia pastoris”[J. Immunol. Methods Volume 386/1–2 (2012) 34–42] S Hamiltonb, H Lia, TA Stadheimb Journal of Immunological Methods 391, 179, 2013 | | 2013 |
